Literature DB >> 6286496

Herpes simplex virus-specific serum immunoglobulin a: detection in patients with primary or recurrent herpes infections and in healthy adults.

M G Friedman, N Kimmel.   

Abstract

A sensitive radioimmunoassay was used to determine levels of herpes simplex virus (HSV)-specific immunoglobulin A (IgA) in serial serum samples drawn from patients with primary HSV infections and from persons with recurrent HSV infections, and in single samples from 90 healthy adults. Significantly rising HSV IgA titers were detected in patients with primary infections, whereas those with recurrent infections had nonfluctuating titers. Sera of IgG-seropositive healthy adults were all positive for HSV-specific IgA without special pretreatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286496      PMCID: PMC347536          DOI: 10.1128/iai.37.1.374-377.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.

Authors:  J J Ratner; B A Sanford; K O Smith
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

2.  IgG, IgA and IgM antibody responses in patients with acute genital and non-genital herpetic lesions determined by the indirect fluorescent antibody method.

Authors:  I H El Falaky; B F Vestergaard; A Hornsleth
Journal:  Scand J Infect Dis       Date:  1977

Review 3.  Infection with herpes-simplex viruses 1 and 2. 1.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans.

Authors:  R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

5.  A possible role of gamma-A-immunoglobulin in herpes simplex virus infection in man.

Authors:  T Tokumaru
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

6.  Persistence of rubellavirus-specific immunoglobulin M and immunoglobulin A antibodies: investigation of successive serum samples with lowered immunoglobulin G concentration.

Authors:  A Hornsleth; J Leerhoy; P Grauballe; H Spanggaard
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

7.  Antibody to varicella-zoster virus-induced membrane antigen: immunoperoxidase assay with air-dried target cells.

Authors:  H Haikin; S Leventon-Kriss; I Sarov
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

8.  Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus.

Authors:  M Hacham; S Leventon-Kriss; I Sarov
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

9.  Recurrent herpes in the rabbit and man.

Authors:  H E Kaufman; D C Brown; E M Ellison
Journal:  Science       Date:  1967-06-23       Impact factor: 47.728

10.  Solid-phase radioimmunoassay of serum immunoglobulin A antibodies to respiratory syncytial virus and adenovirus.

Authors:  P Halonen; H Bennich; E Torfason; T Karlsson; B Ziola; M T Matikainen; E Hjertsson; T Wesslen
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

View more
  8 in total

1.  Virus-specific IgA in serum, saliva, and tears of children with measles.

Authors:  M G Friedman; M Phillip; R Dagan
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.

Authors:  H W Doerr; M Rentschler; G Scheifler
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

3.  Tear and serum antibody levels in ocular herpetic infection: diagnostic precision of secretory IgA.

Authors:  P D Fox; P T Khaw; B W McBride; J I McGill; K A Ward
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

4.  Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns.

Authors:  M G Friedman; B Segal; R Zedaka; B Sarov; M Margalith; R Bishop; R Dagan
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

5.  Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.

Authors:  A E Wittek; A M Arvin; C M Koropchak
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

6.  The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.

Authors:  Derek J Royer; Meghan M Carr; Hem R Gurung; William P Halford; Daniel J J Carr
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.422

7.  B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin.

Authors:  Emily S Ford; Anton M Sholukh; RuthMabel Boytz; Savanna S Carmack; Alexis Klock; Khamsone Phasouk; Danica Shao; Raabya Rossenkhan; Paul T Edlefsen; Tao Peng; Christine Johnston; Anna Wald; Jia Zhu; Lawrence Corey
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

8.  Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.

Authors:  Adrien Bosseboeuf; Célia Seillier; Nicolas Mennesson; Sophie Allain-Maillet; Maeva Fourny; Anne Tallet; Eric Piver; Philippe Lehours; Francis Mégraud; Laureline Berthelot; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.